KLRK1 and neoplasm: NKG2D (natural killer group 2, member D) is an activating immune receptor associated with tumor immunosurveillance, normally expressed on all NK cells, CD8+ T cells, subsets of γδT cells, and some autoreactive CD4+ T cells (4).